-
Product Insights
NewImbed Biosciences Inc Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Imbed Biosciences Inc Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Imbed Biosciences Inc (Imbed) operates as a medical device company that develops technologies for imbedding bioactive molecules in wound dressings and surgical implants. The company’s polymeric microfilm product platform develops bioactive molecules on tissue surfaces to manage wound infections, biofilms, and local pain and support wound healings. It conducts research for the development of antibacterial, antibiofilm and analgesic wound...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Cebranopadol in Pain
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Cebranopadol in Pain report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Cebranopadol in Pain Drug Details: Cebranopadol (GRT-6005) is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Cebranopadol in Opium (Opioid) Addiction
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Cebranopadol in Opium (Opioid) Addiction report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Cebranopadol in Opium (Opioid) Addiction Drug Details: Cebranopadol (GRT-6005) is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Esmethadone Hydrochloride in Liver Failure (Hepatic Insufficiency)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Esmethadone Hydrochloride in Liver Failure (Hepatic Insufficiency) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Esmethadone Hydrochloride in Liver Failure (Hepatic Insufficiency) Drug...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Esmethadone Hydrochloride in Renal Failure
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Esmethadone Hydrochloride in Renal Failure report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Esmethadone Hydrochloride in Renal Failure Drug Details: REL-1017 (D-methadone) is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Tonmya in Fibromyalgia (Fibromyalgia Syndrome)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Tonmya in Fibromyalgia (Fibromyalgia Syndrome) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Tonmya in Fibromyalgia (Fibromyalgia Syndrome) Drug Details: TNX-102 SL (cyclobenzaprine...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Cebranopadol in Chronic Low Back Pain (CLBP)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Cebranopadol in Chronic Low Back Pain (CLBP) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Cebranopadol in Chronic Low Back Pain (CLBP) Drug...
-
Product Insights
Likelihood of Approval Analysis for Influenzavirus B Infections
Overview How likely is it that the drugs in Influenzavirus B Infections will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Influenzavirus B Infections Overview Type B influenza is a subtype of...
-
Product Insights
NewMEDRx Co Ltd Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our MEDRx Co Ltd Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. MEDRx Co Ltd (MEDRx) through its subsidiaries carries out development of pharmaceutical drug based on the transdermal absorption system. The company focuses on ionic liquid technology to develop ionic liquid transdermal system (ILTS) and transdermal medicines that include ETOREAT, MRX-10XT, MRX-5LBT, MRX-4TZT and MRX-5DML. The company also develops anti-Alzheimer's drugs, local analgesics and antidepressants. MEDRx also offers microneedle array...
-
Product Insights
NewMallinckrodt Plc Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Mallinckrodt Plc Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Mallinckrodt Plc (Mallinckrodt) develops, produces, markets, and distributes specialty pharmaceutical products and therapies. The company offers branded pharmaceutical products for autoimmune and rare diseases in specialty areas such as rheumatology, nephrology, neurology, pulmonology and ophthalmology. It also offers immunotherapy, oncology and neonatal respiratory critical care therapies; analgesics and gastrointestinal products. The company offers specialty generic drugs and active pharmaceutical ingredients....